INTERNATIONAL PATENT: THERIVA BIOLOGICS S.L. FILES APPLICATION FOR "MODIFIED ADENOVIRUS BY HEXON HYPERVARIABLE REGION 7 (HVR7) GENE INSERTION"

GENEVA, March 2 -- THERIVA BIOLOGICS S.L. (Sant Cugat del Valles08174 Barcelona) filed a patent application (PCT/IB2025/058364) for "MODIFIED ADENOVIRUS BY HEXON HYPERVARIABLE REGION 7 (HVR7) GENE INSERTION" on Aug 18, 2025. With publication no. WO/2026/042009, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BONASTRE, Ramon Alemany (c/o Theriva Biologics S.L.Sant Cugat del Valles08174 Barcelona), ROJAS EXPOSITO, Luis Alfonso (c/o Theriva Biologics S.L.Sant Cugat del Valles08174 Barcelona), CASCALLO PIQUERAS, Manel Maria (...